• Info
  • Insider Ownership

Insider Trading & Ownership of Joseph S. Zakrzewski

Location
New Hope, PA
Summary
The estimated net worth of Joseph S. Zakrzewski is at least $1,662,777 dollars as of 23 May 2025. Joseph S. Zakrzewski is the Director of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $739.5K. Joseph S. Zakrzewski is the Director of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $636.3K. Joseph S. Zakrzewski is the Director of AMARIN CORP PLC\UK and owns shares of AMARIN CORP PLC\UK (AMRN) stock worth about $263.9K. Joseph S. Zakrzewski is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $23.2K.
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
All Insider Reports
All Insider Reports

Notify me when Joseph S. Zakrzewski files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Joseph S. Zakrzewski

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ANTX AN2 Therapeutics, Inc. Director $739,451 22 May 2025
CYT Cyteir Therapeutics, Inc. Director $636,268 06 Feb 2024
AMRN AMARIN CORP PLC\UK Director $263,865 14 Dec 2021
SGMO SANGAMO THERAPEUTICS, INC Director $23,193 25 Feb 2022
XLRN ACCELERON PHARMA INC Director 19 Nov 2021

Insider Transactions Reported by Joseph S. Zakrzewski:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.